In 2013, R&D spending in US dollars for 21 major publicly held analytical instrument and lab product firms (see table, page 6) rose 4.5%, the slowest pace in IBO’s annual survey of R&D expenditures since 2009 (the companies included are changed annually). The primary reason for slower R&D growth was the lack of significant acquisitions. […]
IVD relies on a number of technologies to test for certain conditions, diseases and infections. Molecular diagnostic (MDx) tests use genomic and proteomic technologies for such analyses. The February 2014 Strategic Directions International report, “The Coveted Molecular Diagnostics Market: From Clinical Research to Diagnosis and Personalized Medicine—Innovative Technologies Break Through,” covers the use of nucleic […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
